^
Association details:
| Biomarker: | ALK translocation |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Drug: | Lorbrena (lorlatinib) (ALK inhibitor, ROS1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
03/29/2022
Excerpt:
Soft Tissue Sarcoma...Inflammatory Myofibroblastic Tumor (IMT) with Anaplastic Lymphoma Kinase (ALK) Translocation...Preferred regimens...Lorlatinib
